首页> 外文期刊>Nucleic acids research >An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb
【24h】

An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb

机译:HIV-1 TAR的超高亲和力配体揭示了P-TEFb识别的RNA结构

获取原文
           

摘要

The HIV-1 trans-activator protein Tat binds the trans-activation response element (TAR)?to facilitate recruitment of the super elongation complex (SEC) to enhance transcription of the integrated pro-viral genome. The Tat–TAR interaction is critical for viral replication and the emergence of the virus from the latent state, therefore, inhibiting this interaction has long been pursued to discover new anti-viral or latency reversal agents. However, discovering active compounds that directly target RNA with high affinity and selectivity remains a significant challenge; limiting pre-clinical development. Here, we report the rational design of a macrocyclic peptide mimic of the arginine rich motif of Tat, which binds to TAR with low pM affinity and 100-fold selectivity against closely homologous RNAs. Despite these unprecedented binding properties, the new ligand (JB181) only moderately inhibits Tat-dependent reactivation in cells and recruitment of positive transcription elongation factor (P-TEFb) to TAR. The NMR structure of the JB181–TAR complex revealed that the ligand induces a structure in the TAR loop that closely mimics the P-TEFb/Tat1:57/AFF4/TAR complex. These results strongly suggest that high-affinity ligands which bind the UCU bulge are not likely to inhibit recruitment of the SEC and suggest that targeting of the TAR loop will be an essential feature of effective Tat inhibitors.
机译:HIV-1反式激活蛋白Tat与反式激活反应元件(TAR)结合,以促进超伸长复合物(SEC)的募集,以增强整合的前病毒基因组的转录。 Tat-TAR相互作用对于病毒复制和病毒从潜伏状态的出现至关重要,因此,长期以来一直在寻求抑制这种相互作用的方法以发现新的抗病毒或潜伏期逆转剂。然而,发现以高亲和力和选择性直接靶向RNA的活性化合物仍然是一项重大挑战。限制了临床前的发展。在这里,我们报告了Tat的精氨酸丰富基序的大环肽模拟物的合理设计,它以低pM亲和力和对紧密同源RNA的100倍选择性与TAR结合。尽管具有这些前所未有的结合特性,但新的配体(JB181)仅适度抑制细胞中Tat依赖性的再激活以及将正转录延伸因子(P-TEFb)募集到TAR。 JB181–TAR复合物的NMR结构表明,配体在TAR环中诱导了一个结构,该结构紧密模拟P-TEFb / Tat1:57 / AFF4 / TAR复合物。这些结果强烈表明,结合UCU凸起的高亲和力配体不太可能抑制SEC的募集,并且表明靶向TAR环将是有效的Tat抑制剂的基本特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号